equityflowunderstand the flow and follow it
EquityFlow › Companies › Re-Vana Therapeutics

Re-Vana Therapeutics

Biotech · Belfast, GB · re-vana.com

Queen's University Belfast spin-out developing sustained-release ocular drug delivery technology.

In the network

Shares the most investors with (number = shared investors):
AntennaWare 2Aramune Technologies 2CV6 Therapeutics 2GenoMe Diagnostics 2LoyalBe 2VascVersa 2

Funding history

DateRoundAmount
Dec 2022Series A
Belfast-based Re-Vana Therapeutics raised an oversubscribed $11.9m Series A led by Visionary Ventures to advance its ocular drug delivery technology.
$11.9M

Investors

Tap an investor to see what else they have backed.

Co-Fund NIExSight VenturesInFocus Capital PartnersQUBISTechstart VenturesVisionary Ventures

Other companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca

Other companies in GB

Capsa AI01HealthRem3dy HealthNewOrbitJoyvié HealthFuse EnergyAirspeedSembleWordsmithOxford Quantum CircuitsFreshaImperagen

Other companies at Series A stage

&Done&Open011h01Health1000 Satellites100ms11x.ai12 Pharmacy180° Seguros1X Technologies1k Kirana Bazaar207
Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.